[HTML][HTML] A hot-melt extrusion risk assessment classification system for amorphous solid dispersion formulation development
SO Kyeremateng, K Voges, S Dohrn, E Sobich… - Pharmaceutics, 2022 - mdpi.com
Several literature publications have described the potential application of active
pharmaceutical ingredient (API)–polymer phase diagrams to identify appropriate …
pharmaceutical ingredient (API)–polymer phase diagrams to identify appropriate …
[HTML][HTML] A Hot-Melt Extrusion Risk Assessment Classification System for Amorphous Solid Dispersion Formulation Development
SO Kyeremateng, K Voges, S Dohrn, E Sobich… - …, 2022 - ncbi.nlm.nih.gov
Several literature publications have described the potential application of active
pharmaceutical ingredient (API)–polymer phase diagrams to identify appropriate …
pharmaceutical ingredient (API)–polymer phase diagrams to identify appropriate …
A Hot-Melt Extrusion Risk Assessment Classification System for Amorphous Solid Dispersion Formulation Development.
SO Kyeremateng, K Voges, S Dohrn… - …, 2022 - search.ebscohost.com
Several literature publications have described the potential application of active
pharmaceutical ingredient (API)–polymer phase diagrams to identify appropriate …
pharmaceutical ingredient (API)–polymer phase diagrams to identify appropriate …
A Hot-Melt Extrusion Risk Assessment Classification System for Amorphous Solid Dispersion Formulation Development
SO Kyeremateng, K Voges, S Dohrn… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Several literature publications have described the potential application of active
pharmaceutical ingredient (API)-polymer phase diagrams to identify appropriate …
pharmaceutical ingredient (API)-polymer phase diagrams to identify appropriate …
[PDF][PDF] A Hot-Melt Extrusion Risk Assessment Classification System for Amorphous Solid Dispersion Formulation Development. Pharmaceutics 2022, 14, 1044
SO Kyeremateng, K Voges, S Dohrn, E Sobich… - 2022 - researchgate.net
Several literature publications have described the potential application of active
pharmaceutical ingredient (API)–polymer phase diagrams to identify appropriate …
pharmaceutical ingredient (API)–polymer phase diagrams to identify appropriate …
A Hot-Melt Extrusion Risk Assessment Classification System for Amorphous Solid Dispersion Formulation Development.
SO Kyeremateng, K Voges, S Dohrn, E Sobich… - …, 2022 - europepmc.org
Several literature publications have described the potential application of active
pharmaceutical ingredient (API)–polymer phase diagrams to identify appropriate …
pharmaceutical ingredient (API)–polymer phase diagrams to identify appropriate …
A Hot-Melt Extrusion Risk Assessment Classification System for Amorphous Solid Dispersion Formulation Development
SO Kyeremateng, K Voges, S Dohrn, E Sobich… - …, 2022 - search.proquest.com
Several literature publications have described the potential application of active
pharmaceutical ingredient (API)–polymer phase diagrams to identify appropriate …
pharmaceutical ingredient (API)–polymer phase diagrams to identify appropriate …